whereas in Bermuda 68 and 94% were suscepitible to ampicillin and cephalothin, respectively (1) . Haemophilus influenzae and N. gonorrhoeae isolates show susceptibility profiles similar to those of strains isolated in a U.S. hospital of comparative size (4, 7) .
Methicillin-susceptible S. aureus (MSSA) showed 92% susceptibility to erythromycin, compared to 70% susceptibility in a U.S. hospital of similar size. The first outbreak of MRSA in Bermuda occurred in 1990. The MRSA rate is 3.5%, well below the U.S. rate of 10 to 30% (4, 7). Stringent hand-washing practices and a comprehensive MRSA-VRE screening policy for patients returning from hospitalization abroad may be responsible for the low MRSA rate.
In 1994, the first PRSP strain was isolated at KEMH by using a 1-g oxacillin disc for screening (6) . During the period August 1993 to July 1998, there were 502 S. pneumoniae isolates, of which 3% were resistant or of intermediate susceptibility to penicilllin. Only one was resistant to cefotaxime. In 1994 to 1995, the Centers for Disease Control reported that 23% of S. pneumoniae isolates in the United States were resistant to penicillin (3). In 1990, 100% of S. pneumoniae isolates in Iceland were susceptible to penicillin, and by 1996 only 60 to 70% were susceptible (9) .
The first isolation of a VRE strain at KEMH was in 1995. Subsequently 13 patients have been colonized or infected with VRE. All VRE isolates have been imported from abroad. There has been no nosocomial transmission of VRE within KEMH. High-level aminoglycocide resistance has not been observed in Enterococcus spp. other than VRE isolates.
Antibiotic utilization controls have been in place for several years at KEMH. The pharmacy instituted formulary controls over 20 years ago. The microbiology laboratory has been selectively reporting antibiotic susceptibilities for 15 years. Three years ago, MRSA and VRE screening procedures were implemented for patients hospitalized abroad. We believe this collaborative effort has been a major factor in the control of antibiotic resistance in Bermuda. 
